James Wright, MD
Family Medicine · Louisville, KYNPI 1245234053
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.3% of the total across 751 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 52 manufacturers, the largest accounting for just 13.9% — the pattern of someone who eats at a lot of different presentations. Among family medicine clinicians in KY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 751 payments — averaging $23.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$2K
- Novo Nordisk$2K
- GSK$1K
- AbbVie$1K
- Amgen$1K
- Novartis$1K
- plus $9K from 46 others
What the payments were for
- Food & beverage$17,76499%
- Education$1171%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FARXIGA$543
- AIRSUPRA$424
- BREZTRI$404
- JARDIANCE$355
- REXULTI$354
- AREXVY$345
- LOKELMA$337
- JATENZO$329
- LEQVIO$252
- TRELEGY ELLIPTA$248
- CAPLYTA$247
- SYNCHROMEDII$243
- ENTRESTO$239
- GENERAL PAIN MANAGEMENT$231
- NEXLIZET$201
- NEXLETOL$201
- MINIMED 780G$127
- Jornay PM 20mg capsules (Bottle of 100)$125
- XARELTO$124
- Ozempic$122
How this compares
$17,882 in reported general payments places this provider in the 95th percentile of 1,559 family medicine providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 79 | $123,274 |
| JardianceEmpagliflozin | 76 | $120,924 |
| FarxigaDapagliflozin Propanediol | 86 | $92,478 |
| EliquisApixaban | 63 | $78,101 |
| Repatha SureclickEvolocumab | 95 | $72,445 |
| TrulicityDulaglutide | 36 | $58,074 |
| MounjaroTirzepatide | 14 | $29,109 |
| KerendiaFinerenone | 19 | $28,215 |
| LinzessLinaclotide | 22 | $26,860 |
| VascepaIcosapent Ethyl | 38 | $26,620 |
| Janumet XrSitagliptin Phos/Metformin Hcl | 19 | $26,096 |
| Nurtec OdtRimegepant Sulfate | 13 | $24,573 |
| XareltoRivaroxaban | 20 | $23,856 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 25 | $23,427 |
| JanuviaSitagliptin Phosphate | 15 | $23,081 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance, Stiolto Respimat | $796 | $126,14887 claims |
| Novo NordiskOzempic | $1,617 | $123,27479 claims |
| PfizerEliquis, Nurtec Odt | $670 | $102,67476 claims |
| AstraZenecaFarxiga | $2,491 | $92,47886 claims |
| Lilly USA, LLCTrulicity, Mounjaro | $542 | $87,18350 claims |
| MerckJanumet Xr, Januvia | $117 | $49,17634 claims |
| AbbVieLinzess, Synthroid | $1,486 | $33,951161 claims |
| BayerKerendia | $409 | $28,21519 claims |
| Johnson & JohnsonXarelto | $935 | $23,85620 claims |
| GSKTrelegy Ellipta | $1,493 | $23,42725 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $64 | $22,39324 claims |
| Kowa Pharmaceuticals America, Inc.Livalo | $109 | $11,50812 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,559 family medicine providers in Kentucky.
Other family medicine in Louisville
- Christopher RhyneLouisville$933K
- Suraj GathaniLouisville$69K
- Mandy WhittLouisville$38K
- Michael PendletonLouisville$29K
- Rajanbhai AminLouisville$26K
- Rosenberg ReyesLouisville$18K
- Dennis GrayLouisville$14K
- Vincent LangLouisville$12K
- Jaivanti LohanoLouisville$11K
- John RichardLexington$226K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.